Morita Iwami

This inventor holds 15 USPTO granted patents, primarily in Pharmaceutical Chemistry. Top assignee: Fujisawa Pharmaceutical Company, Ltd.. Active years: 1986-1997.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Morita Iwami. Retrieved from https://idiyas.com/inventor/morita-iwami

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 15

% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 4

Forward Citations = 48(Granted Patents)

Location History:

Takarazuka, JP (1986 - 1989)
Ibaraki, JP (1989)
Tsukuba, JP (1990 - 1997)

Company Filing History:

15 out of 940

Fujisawa Pharmaceutical Company, Ltd.

patents

Years Active: 1986-1997

Loading Chart...

Areas of Expertise:

Cephalosporin

Acylase

Nitro Compounds

Tetracyclo Compounds

Pharmaceutical Composition

Streptomyces

Biologically Active

Tumor Treatment

Production Process

7-Aminocephem

GL-7ACA

15 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 5677141 - Process for producing 7-aminocephem compound or salts thereof (1997-10-14),

2. 5320948 - Cephalosporin C acylase (1994-06-14),

3. 5312750 - GL-7ACA acylase (1994-05-17),

4. 5310659 - GL-7ACA acylase (1994-05-10),

5. 5192678 - Cephalosporin C acylase (1993-03-09),

6. 4950605 - FR-900493 substance, a process for its production and a pharmaceutical (1990-08-21),

7. 4863926 - Nitro aliphatic compounds, process for preparation thereof and use (1989-09-05),

8. 4861774 - Method of treating tumors using tetracyclo compounds (1989-08-29),

9. 4782088 - Nitro aliphatic compounds and use thereof (1988-11-01),

10. 4778804 - Nitro aliphatic compounds, process for preparation thereof and use (1988-10-18),

11. 4767768 - Nitro aliphatic compounds, process for preparation thereof and use (1988-08-30),

12. 4743555 - Biologically pure culture of Streptomyces sandaensis No. 6897 (1988-05-10),

13. 4661352 - WS 7739 substances, their preparation and pharmaceutical composition (1987-04-28),

14. 4645765 - Tetracyclo compounds and a pharmaceutical composition containing the same (1987-02-24),

15. 4578271 - Biologically active WS 6049 substances, a process for the production (1986-03-25),

Title: **The Innovative Contributions of Inventor Morita Iwami**

Introduction

Morita Iwami, an esteemed inventor based in Takarazuka, Japan, has made significant strides in the field of pharmaceutical innovations. With a total of 15 patents to her name, she has specialized in processes that enhance the production and efficacy of important compounds in medicinal chemistry.

Latest Patents

Among her latest inventions is a groundbreaking process for producing 7-aminocephem compounds or salts thereof. This invention emphasizes the use of microorganisms that are transformed with a specific vector, enabling the conversion of cephalosporin compounds into valuable 7-aminocephem compounds. Additionally, her patent concerning the Cephalosporin C acylase derived from *Pseudomonas diminuta N-176* highlights its ability to catalyze the conversion of several cephalosporin-related substances into 7-aminocephalosporanic acid. The significant attributes of this enzyme are its two subunits, one with a molecular weight of 26 kDa and the other of 58 kDa. Furthermore, she has developed a methodology for the recombinant production of this cephalosporin C acylase in *Escherichia coli*.

Career Highlights

Throughout her career, Morita has been associated with Fujisawa Pharmaceutical Company, Ltd., a leading organization in the pharmaceutical industry. Her innovative research and development efforts have not only advanced her company's goals but have also contributed to the broader realm of medicinal chemistry.

Collaborations

Working alongside talented individuals such as Masanobu Kohsaka and Shigehiro Takase, Morita has been part of a collaborative effort that underscores the importance of teamwork in innovative research. Their combined expertise has further propelled the advancements in pharmaceutical technologies.

Conclusion

Morita Iwami's contributions to the field of pharmaceuticals exemplify dedication to innovation and research. With her impressive patent portfolio and collaborative spirit, she continues to inspire future generations of inventors and researchers in their pursuit of groundbreaking advancements in medicine.

Profile summary based on public USPTO records.

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]